Nucleobase and nucleoside analogues: resistance and re-sensitisation at the level of pharmacokinetics, pharmacodynamics and metabolism

N Tsesmetzis, CBJ Paulin, SG Rudd, N Herold - Cancers, 2018 - mdpi.com
Antimetabolites, in particular nucleobase and nucleoside analogues, are cytotoxic drugs
that, starting from the small field of paediatric oncology, in combination with other …

Implementing a functional precision medicine tumor board for acute myeloid leukemia

D Malani, A Kumar, O Brück, M Kontro, B Yadav… - Cancer discovery, 2022 - AACR
We generated ex vivo drug-response and multiomics profiling data for a prospective series
of 252 samples from 186 patients with acute myeloid leukemia (AML). A functional precision …

Clinical implications of inflammation in acute myeloid leukemia

C Récher - Frontiers in Oncology, 2021 - frontiersin.org
Recent advances in the description of the tumor microenvironment of acute myeloid
leukemia, including the comprehensive analysis of the leukemic stem cell niche and clonal …

Carrier-free nanoplatform via evoking pyroptosis and immune response against breast cancer

L Li, H Tian, Z Zhang, N Ding, K He, S Lu… - … applied materials & …, 2022 - ACS Publications
Pyroptosis, as a novel mode of cell death, has been proven to have impressive antitumor
effects. Dying cells undergoing pyroptosis can elicit antitumor immunity by the release of …

Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed/refractory acute myeloid leukemia

K Li, Y Du, Y Cai, W Liu, Y Lv, B Huang, L Zhang… - Leukemia, 2023 - nature.com
Chemoresistance and relapse are the leading cause of AML-related deaths. Utilizing single-
cell RNA sequencing (scRNA-seq), we dissected the cellular states of bone marrow samples …

The glucocorticoid receptor associates with the cohesin loader NIPBL to promote long-range gene regulation

L Rinaldi, G Fettweis, S Kim, DA Garcia, S Fujiwara… - Science …, 2022 - science.org
The cohesin complex is central to chromatin loo**, but mechanisms by which these long-
range chromatin interactions are formed and persist remain unclear. We demonstrate that …

Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia

I Laverdière, M Boileau, AL Neumann, H Frison… - Blood cancer …, 2018 - nature.com
Therapy for acute myeloid leukemia (AML) involves intense cytotoxic treatment and yet
approximately 70% of AML are refractory to initial therapy or eventually relapse. This is at …

Inhibition of exosome release sensitizes U937 cells to PEGylated liposomal doxorubicin

S Hekmatirad, M Moloudizargari… - Frontiers in …, 2021 - frontiersin.org
Aims Acute myeloblastic leukemia (AML) is the most common type of acute leukemia in
adults. Despite numerous treatment strategies including chemotherapy and radiotherapy, a …

Improved outcome for AML patients over the years 2000–2014

S Bertoli, S Tavitian, A Huynh, C Borel… - Blood cancer …, 2017 - nature.com
Few recent studies from registries have reported an improvement in overall survival of
younger patients with acute myeloid leukemia (AML). However, reasons for this …

Hyperleukocytosis and leukostasis in acute and chronic leukemias

W Macaron, Z Sargsyan, NJ Short - Leukemia & Lymphoma, 2022 - Taylor & Francis
Leukostasis is a life-threatening complication of high concentrations of circulating leukemic
cells, most often myeloblasts. Effective care of patients with leukostasis involves early …